← Companies
Sponsor / Institution
Chang Gung Memorial Hospital
Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.
Programs
3
linked to organization
Strong Evidence
0
0 status confirmed
Details Checked
3
0 open data checks
Company / Institution Links
0 / 3
industry vs non-industry records
Competitive Density
4
Pipeline Velocity
23
Completion Signal
0
Programs by Stage
Phase 22
Not applicable1
Trial / Program Status
Active1
Completed1
Unknown1
Modality Mix
Small Molecule3
Indication Coverage
Hearing Loss2
Sensorineural Hearing Loss2
Tinnitus2
Noise-Induced Hearing Loss1
Sudden Hearing Loss1
Sudden Sensorineural Hearing Loss1
Program Types
Therapeutic3
Population Tags
adult3
sensorineural2
sudden2
tinnitus2
combination-study1
noise-induced1
Strong-Evidence Records
0 recordsNo strong-evidence records are linked to this organization yet.
Checked Records With Caveats
3 checked · 0 open checksZinc gluconate tinnitus and noise-induced hearing-loss study
Details checked
Small MoleculeNot applicableCompleted
Single-group study assessing two months of oral zinc gluconate in patients with tinnitus and typical noise-induced hearing loss.
Data checks: institution-led-study, registry-only-evidence
Chang Gung Topiramate Adjunct Study for Sudden Sensorineural Hearing Loss
Details checked
Small MoleculePhase 2Unknown
Phase 2 institution-led trial evaluating oral topiramate added to standard systemic/intratympanic steroid therapy for sudden sensorineural hearing loss.
Data checks: institution-led-study, registry-only-evidence
Chang Gung hydroxychloroquine adjunct SSNHL study
Details checked
Small MoleculePhase 2Active
Oral hydroxychloroquine 400 mg/day for 60 days added to oral prednisolone steroid care, compared with steroid care alone, for sudden sensorineural hearing loss recovery.
Data checks: merged-generated-intervention-arms, institution-led-study